Study on the bioavailability of Atenolol tablet
Peng Wen-xin
Abstract
Peng Wen-xin
Abstract
Objective:To establish a method to determine atenolol concentration in plasma by SPE-HPLC,and to study relative bioavailability of atenolol tablet.Methods:The atenolol concentrations in plasma through solid-phase extraction were determined by HPLC method following a single oral dose were given to 12 volunteers.Results:RSD of intra-day and inter-day were less than 10% and recovery rates of plasma coincided for pharmacokinetic study.The pharmacokinetic parameters of experimental tablets and comparative tablets AUC 0~36 ?C max ?T max ?t 1/2 was 5150 35±1172 52ng·h/ml and 5466 50±1277 08ng·h/ml,717 04±189 69ng/ml and 678 63±193 36ng/ml,2 42±0 45h and 2 63±0 54h,7 84±1 25h and 7 73±1 59h.There were no significant different between the two in formulations in the AUC T max ?C max .Conclusion:The SPE-HPLC method to determine atenolol concentration is a good method.The two formulations were bioequivalent,the relative bioavailbility was 94 22%.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To establish a method to determine atenolol concentration in plasma by SPE-HPLC,and to study relative bioavailability of atenolol tablet.Methods:The atenolol concentrations in plasma through solid-phase extraction were determined by HPLC method following a single oral dose were given to 12 volunteers.Results:RSD of intra-day and inter-day were less than 10% and recovery rates of plasma coincided for pharmacokinetic study.The pharmacokinetic parameters of experimental tablets and comparative tablets AUC 0~36 ?C max ?T max ?t 1/2 was 5150 35±1172 52ng·h/ml and 5466 50±1277 08ng·h/ml,717 04±189 69ng/ml and 678 63±193 36ng/ml,2 42±0 45h and 2 63±0 54h,7 84±1 25h and 7 73±1 59h.There were no significant different between the two in formulations in the AUC T max ?C max .Conclusion:The SPE-HPLC method to determine atenolol concentration is a good method.The two formulations were bioequivalent,the relative bioavailbility was 94 22%.
Key concepts: Atenolol, Bioavailability, Bioequivalence, Pharmacokinetics, Chromatography, High-performance liquid chromatography, Chemistry, Plasma concentration